Expression pattern of chemokine receptors and chemokine release in inflammatory erythroderma and Sézary syndrome

Dermatology

Volumn 213, Issue 4, 2006, Pages 284-292

  Fierro, Maria Teresa ^a   Comessatti, Alessandra ^a   Quaglino, Pietro ^a   Ortoncelli, Michela ^a   Osella Abate, Simona ^a   Ponti, Renata ^a   Novelli, Mauro ^a   Bernengo, Maria Grazia ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

CD26 activation molecule; Chemokine receptors; Chemokines; Erythroderma; S zary syndrome

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; DIPEPTIDYL PEPTIDASE IV; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE DERIVED CHEMOKINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHRODERMA; FEMALE; FLOW CYTOMETRY; HUMAN; INFLAMMATORY DISEASE; LYMPHOCYTIC INFILTRATION; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEZARY SYNDROME; SKIN INFILTRATE; SKIN INFLAMMATION; T CELL LYMPHOMA; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ADULT; AGED; AGED, 80 AND OVER; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CHEMOKINES, CC; CHEMOTAXIS, LEUKOCYTE; DERMATITIS, EXFOLIATIVE; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE; SEZARY SYNDROME; SKIN NEOPLASMS; TH1 CELLS; TH2 CELLS;

EID: 33751502698     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096191     Document Type: Article

References (43)

1. Akhyani M, Ghodsi ZS, Toosi S, Dabbaghian H: Erythroderma: a clinical study of 97 cases. BMC Dermatol 2005;5:5.
2. Sehgal VN, Srivastava G, Sardana K: Erythroderma/exfoliative dermatitis: a synopsis. Int J Dermatol 2004;43:39-47.
3. Rothe MJ, Bialy TL, Grant-Kels JM: Erythroderma. Dermatol Clin 2000;18:405-415.
4. Lutzner M, Edelson R, Schein P, Green I, Kirkpatrick C, Ahmed A: Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides and related disorders. Ann Intern Med 1975;83:534-552.
5. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJ: EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Classification for Research and Treatment of Cancer. Blood 1997;90:354-371.
6. Russell-Jones R: Diagnosing erythrodermic cutaneous T-cell lymphoma. Br J Dermatol 2005;153:1-5.
7. Bernengo MG, Novelli M, Quaglino P, Lisa F, De Matteis A, Savoia P, Cappello N, Fierro MT: The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells. Br J Dermatol 2001;144:125-135.
8. Jones D, Dang NH, Duvic M, Washington LT, Huh YO: Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol 2001;115:885-892.
9. Narducci MG, Scala E, Bresin A, Caprini E, Picchio MC, Remotti D, Ragone G, Nasorri F, Frontani M, Arcelli D, Volinia S, Lombardo GA, Baliva G, Napolitano M, Russo G: Skin-homing of Sézary cells involves SDF-1-CXCR4 signaling and downregulation of CD26/dipeptidylpeptidase IV. Blood 2005;107:1108-1115.
10. Poszepczynska-Guigne E, Schiavon V, D'Incan M, Echchakir H, Musette P, Ortonne N, Boumsell L, Moretta A, Bensussan A, Bagot M: CD158k/KIR3DL2 is a new phenotypic marker of Sézary cells: relevance for the diagnosis and follow-up of Sézary syndrome. J Invest Dermatol 2004;122:820-823.
11. Poenitz N, Simon-Ackermann J, Gratchev A, Qadoumi M, Klemke CD, Stadler R, Kremer A, Radenhausen M, Henke U, Assaf C, Utikal J, Goerdt S, Dippel E: Overexpression of c- myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma. Dermatology 2005;211:84-92.
12. Baggiolini M: Chemokines in pathology and medicine. J Intern Med 2001;250:91-104.
13. Baggiolini M, Loetscher P: Chemokines in inflammation and immunity. Immunol Today 2000;21:418-420.
14. Taub DD, Oppenheim JJ: Chemokines, inflammation and the immune system. Ther Immunol 1994;1:229-246.
15. Sallusto F, Lanzavecchia A, Mackay CR: Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 1998;19:568-574.
16. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187:129-134.
17. D'Ambrosio D, Iellem A, Bonecchi R, Mazzeo D, Sozzani S, Mantovani A, Sinigaglia F: Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol 1998;161:5111-5115.
18. Okazaki H, Kakurai M, Hirata D, Sato H, Kamimura T, Onai N, Matsushima K, Nakagawa H, Kano S, Minota S: Characterization of chemokine receptor expression and cytokine production in circulating CD4+ T cells from patients with atopic dermatitis: up-regulation of C-C chemokine receptor 4 in atopic dermatitis. Clin Exp Allergy 2002;32:1236-1242.
19. Vestergaard C, Deleuran M, Gesser B, Gronhoj Larsen C: Expression of the T-helper 2-specific chemokine receptor CCR4 on CCR10-positive lymphocytes in atopic dermatitis skin but not in psoriasis skin. Br J Dermatol 2003;149:457-463.
20. Ferenczi K, Fuhlbrigge RC, Pinkus J, Pinkus GS, Kupper TS: Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol 2002;119:1405-1410.
21. Sokolowska-Wojdylo M, Wenzel J, Gaffal E, Lenz J, Speuser P, Erdmann S, Abuzahra F, Bowman E, Roszkiewicz J, Bieber T, Tuting T: Circulating clonal CLA+ and CD4+ T cells in Sézary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7. Br J Dermatol 2005;152:258-264.
22. Yamaguchi T, Ohshima K, Tsuchiya T, Suehuji H, Karube K, Nakayama J, Suzumiya J, Yoshino T, Kikuchi M: The comparison of expression of cutaneous lymphocyte-associated antigen (CLA), and Th1- and Th2-associated antigens in mycosis fungoides and cutaneous lesions of adult T-cell leukemia/lymphoma. Eur J Dermatol 2003;13:553-559.
23. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, Mackay CR: The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998;101:746-754.
24. Nakajima H, Fukuda K, Doi Y, Sugino M, Kimura F, Hanafusa T, Ikemoto T, Shimizu A: Expression of TH1/TH2-related chemokine receptors on peripheral T cells and correlation with clinical disease activity in patients with multiple sclerosis. Eur Neurol 2004;52:162-168.
25. Mohan K, Cordeiro E, Vaci M, McMaster C, Issekutz TB: CXCR3 is required for migration to dermal inflammation by normal and in vivo activated T cells: differential requirements by CD4 and CD8 memory subsets. Eur J Immunol 2005;35:1702-1711.
26. Lu D, Duvic M, Medeiros LJ, Luthra R, Dorfman DM, Jones D: The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides. Am J Clin Pathol 2001;115:413-421.
27. Notohamiprodjo M, Segerer S, Huss R, Hildebrandt B, Soler D, Djafarzadeh R, Buck W, Nelson PJ, von Luettichau I: CCR10 is expressed in cutaneous T-cell lymphoma. Int J Cancer 2005;115:641-647.
28. Kallinich T, Muche JM, Qin S, Sterry W, Audring H, Kroczek RA: Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides. J Invest Dermatol 2003;121:1045-1052.
29. Vonderheid EC, Bernengo MG: The Sézary syndrome: hematologic criteria. Hematol Oncol Clin North Am 2003;17:1367-1389.
30. Bernengo MG, Quaglino P, Novelli M, Cappello N, Doveil GC, Lisa F, De Matteis A, Fierro MT, Appino A: Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features. Ann Oncol 1998;9:857-863.
31. Ponti R, Quaglino P, Novelli M, Fierro MT, Comessatti A, Peroni A, Bonello L, Bernengo MG: TCR-γ gene rearrangement by multiplex PCR/heteroduplex analysis in cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease patients: correlation with clinical, histological and immunophenotypical findings. Br J Dermatol 2005;153:565-573.
32. Klemke CD, Dippel E, Dembinski A, Poniz N, Assaf C, Kummel M, Stein H, Goerdt S: Clonal T cell receptor γ-chain gene rearrangement by PCR-based Genescan analysis in the skin and blood of patients with parapsorias and early-stage mycosis fungoides. J Pathol 2002;197:348-354.
33. Novelli M, Savoia P, Cambieri I, Ponti R, Comessatti A, Lisa F, Bernengo MG: Collagenase digestion and mechanical disaggregation as a method to extract and immunophenotype tumour lymphocytes in cutaneous T-cell lymphomas. Clin Exp Dermatol 2000;25:423-431.
34. Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC: CC chemokine receptor (CCR) 4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 2001;194:1541-1547.
35. H lymphocyte trafficking. Blood 2003;101:1677-1682.
36. Jones D, O'Hara C, Kraus MD, Perez-Atayde AR, Shahsafaei A, Wu L, Dorfman DM: Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood 2000;96:685-690.
37. Rottman JB, Smith TL, Ganley KG, Kikuchi T, Krueger JG: Potential role of the chemokine receptors CXCR3, CCR4, and the integrin αEβ7 in the pathogenesis of psoriasis vulgaris. Lab Invest 2001;81:335-347.
38. Teraki Y, Miyake A, Takebayashi R, Shiohara T: Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris. Clin Exp Dermatol 2004;29:658-663.
39. Andrew DP, Ruffing N, Kim CH, Miao W, Heath H, Li Y, Murphy K, Campbell JJ, Butcher EC, Wu L: C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. J Immunol 2001;166:103-111.
40. Kim CH, Rott L, Kunkel EJ, Genovese MC, Andrew DP, Wu L, Butcher EC: Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 2001;108:1331-1339.
41. Chen L, Martinez O, Overbergh L, Mathieu C, Prabhakar BS, Chan LS: Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model. Clin Exp Immunol 2004;138:375-387.
42. Cancino-Diaz JC, Reyes-Maldonado E, Banuelos-Panuco CA, Jimenez-Zamudio L, Garcia-Latorre E, Leon-Dorantes G, Blancas-Gonzalez F, Paredes-Cabrera G, Cancino-Diaz ME: Interleukin-13 receptor in psoriatic keratinocytes: overexpression of the mRNA and underexpression of the protein. J Invest Dermatol 2002;119:1114-1120.
43. Sarris AH, Esgleyes-Ribot T, Crow M, Broxmeyer HE, Karasavvas N, Pugh W, Grossman D, Deisseroth A, Duvic M: Cytokine loops involving interferon-gamma and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma? Blood 1995;86:651-658.